CN107801990A - A kind of health food of auxiliary hyperglycemic and preparation method thereof - Google Patents
A kind of health food of auxiliary hyperglycemic and preparation method thereof Download PDFInfo
- Publication number
- CN107801990A CN107801990A CN201711238078.7A CN201711238078A CN107801990A CN 107801990 A CN107801990 A CN 107801990A CN 201711238078 A CN201711238078 A CN 201711238078A CN 107801990 A CN107801990 A CN 107801990A
- Authority
- CN
- China
- Prior art keywords
- extract
- fruit
- health food
- chinese
- auxiliary hyperglycemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 21
- 230000003345 hyperglycaemic effect Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 46
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 33
- 244000248557 Ophiopogon japonicus Species 0.000 claims abstract description 23
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 22
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 21
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 21
- 241000405414 Rehmannia Species 0.000 claims abstract description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 15
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 13
- 239000009636 Huang Qi Substances 0.000 claims abstract description 13
- 244000241872 Lycium chinense Species 0.000 claims abstract description 11
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 11
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 10
- 240000000249 Morus alba Species 0.000 claims abstract description 9
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 9
- 229940107666 astragalus root Drugs 0.000 claims abstract description 9
- 235000002723 Dioscorea alata Nutrition 0.000 claims abstract description 7
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims abstract description 7
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims abstract description 7
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims abstract description 7
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims abstract description 7
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 7
- 235000007056 Dioscorea composita Nutrition 0.000 claims abstract description 6
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims abstract description 6
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims abstract description 6
- 241000605447 Anemarrhena Species 0.000 claims abstract description 4
- 229930191283 anemarrhena Natural products 0.000 claims abstract description 4
- 239000000945 filler Substances 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000080 wetting agent Substances 0.000 claims description 11
- 239000000853 adhesive Substances 0.000 claims description 10
- 230000001070 adhesive effect Effects 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 238000003860 storage Methods 0.000 claims description 7
- 229920002774 Maltodextrin Polymers 0.000 claims description 6
- 239000005913 Maltodextrin Substances 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 239000000845 maltitol Substances 0.000 claims description 6
- 235000010449 maltitol Nutrition 0.000 claims description 6
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 6
- 229940035436 maltitol Drugs 0.000 claims description 6
- 229940035034 maltodextrin Drugs 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 229920000881 Modified starch Polymers 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000002002 slurry Substances 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 3
- 238000005453 pelletization Methods 0.000 claims description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims 2
- NBGXQZRRLOGAJF-UHFFFAOYSA-N Maltulose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)(CO)OCC1O NBGXQZRRLOGAJF-UHFFFAOYSA-N 0.000 claims 1
- JCQLYHFGKNRPGE-HFZVAGMNSA-N maltulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-HFZVAGMNSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 48
- 210000004369 blood Anatomy 0.000 abstract description 48
- 230000000694 effects Effects 0.000 abstract description 20
- 235000000346 sugar Nutrition 0.000 abstract description 19
- 230000009467 reduction Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 description 37
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 32
- 239000003814 drug Substances 0.000 description 20
- 230000002218 hypoglycaemic effect Effects 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
- 239000011651 chromium Substances 0.000 description 14
- 206010012601 diabetes mellitus Diseases 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 201000001421 hyperglycemia Diseases 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 229940125396 insulin Drugs 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 208000013016 Hypoglycemia Diseases 0.000 description 4
- 244000241838 Lycium barbarum Species 0.000 description 4
- 235000008422 Schisandra chinensis Nutrition 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 241001061264 Astragalus Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 235000006533 astragalus Nutrition 0.000 description 3
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 210000004233 talus Anatomy 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 241000581650 Ivesia Species 0.000 description 2
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000218989 Trichosanthes Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- -1 malt ketone Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 239000000837 restrainer Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000004638 Dendrobium nobile Species 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 229940122199 Insulin secretagogue Drugs 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 1
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 208000006443 lactic acidosis Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000001084 renoprotective effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a kind of health food of auxiliary hyperglycemic and preparation method thereof.The health food includes following components according to weight percentage:The Radix Astragali or Astragalus Root P.E 1 50%, the root of kudzu vine or kudzu root extract 1 50%, glutinous rehmannia or glutinous rehmannia extract 1 50%, the wind-weed or anemarrhena asphodefoides extract 0 25%, the tuber of dwarf lilyturf or ophiopogon japonicus extract 1 50%, the fruit of Chinese wolfberry or Fructus lycii P.E 0 50%, the fruit of Chinese magnoliavine or fruit of Chinese magnoliavine extraction 1 50%, Chinese yam or yam extract 0 25%, mulberry leaf or mulberry-leaf extract 0 25%, Cr-enriched yeast 0.01 5%.The health food function of blood sugar reduction of the auxiliary hyperglycemic of the present invention is clear and definite, safe without toxic side effect, instant.
Description
Technical field
The present invention relates to field of medicaments, more particularly to a kind of health food of auxiliary hyperglycemic and preparation method thereof.
Background technology
Diabetes are one of most common epidemic diseases of world wide, have become after angiocardiopathy, tumour
The disease of three big serious threat human healths.Patient normally behaves as more drinks, more food, diuresis, weight loss, also with it is fatty,
Protein metabolism is disorderly, easily concurrent vascular lesion, DKA.According to《Chinese residents nourishment and chronic disease status report
(2015)》, 2012 China 18 years old and above diabetic illness rate be 9.7%, patient numbers about 100,000,000.In recent years, with
The improvement of people's living standards, aging population and work and living-pattern preservation, the incidence of disease of hyperglycaemia becomes in rising
Gesture, and tend to rejuvenation.
At present, the conventional treatment drug of diabetes is mainly Insulin secretagogues, alpha-glucosidase restrainer, pancreas islet
The chemicalses such as plain sensitizer and insulin.It is long-term use of although OHA can effectively control blood glucose level in patients
Certain side effect can be produced afterwards, it is possible to further aggravate the infringement of organ, or even drug resistance occur, and administering mode also has
Inconvenience.Simultaneously these medicines to diabetes in advance and chronic complicating diseases are without preferable control effect, easily cause low blood
Sugar or lactic acidosis, and can not prevent the further necrosis of beta Cell of islet, cause insulin the side effect such as to further rely on.
Function of health food is clear and definite, does not have any acute, subacute and chronic hazard to human body, therefore it is convenient to take, easy to be badly in need of development
In storage and the hypoglycemia healthcare food carried.
In long-term medical practice, China's traditional medicine have accumulated many invaluable experiences, and modern pharmacology research shows
Chinese herbal medicine has remarkable effect in terms of preventing and treating diabetes and various chronic complicating diseases." 200310115012.0 is a kind of for patent application
Disclosed in medicine for the treatment of diabetes and preparation method thereof " using American Ginseng, the Radix Astragali, Chinese yam, radix rehmanniae recen, Fructus Corni, matrimony vine
Chinese medicine composition is made in son, the tuber of dwarf lilyturf, the wind-weed, root of Chinese trichosanthes, the fruit of Chinese magnoliavine, Chinese gall, the root of kudzu vine, and it has obvious hypoglycemic work
With.Disclosed in patent application " a kind of traditional Chinese medicinal composition with effect of reducing blood sugar of 201210524373.X " by Semen sesami nigrum, arillus longan, mulberry
Shen, radix rehmanniae recen, the tuber of dwarf lilyturf, root of Chinese trichosanthes, the Radix Astragali, the fruit of Chinese wolfberry, the root of kudzu vine, red ginseng, Poria cocos, moutan bark, the fruit of Chinese magnoliavine, spina date seed, the seed of Oriental arborvitae,
Cortex albiziae, the stem of noble dendrobium, the fruit of Chinese wolfberry, the fruit of glossy privet, the molecular Chinese medicines of lily, Chuan Su, it can improve the symptom of diabetic.
But Chinese medicine composition also has many defects in the prior art, fail to understand such as preparation technology complexity, expensive starting materials, by hypoglycemic effect
The problems such as really or having much room for improvement.
The content of the invention
In view of the above problems, it is an object of the invention to provide a kind of health food of auxiliary hyperglycemic and its preparation side
Method.The health food function of blood sugar reduction of the auxiliary hyperglycemic of the present invention is clear and definite, safe without toxic side effect, instant.
The used to achieve the above object technical scheme of the present invention is:
A kind of health food of auxiliary hyperglycemic, include following components according to weight percentage:
The Radix Astragali or Astragalus Root P.E 1-50%, the root of kudzu vine or kudzu root extract 1-50%, glutinous rehmannia or glutinous rehmannia extract 1-50%,
The wind-weed or anemarrhena asphodefoides extract 0-25%, the tuber of dwarf lilyturf or ophiopogon japonicus extract 1-50%, the fruit of Chinese wolfberry or Fructus lycii P.E 0-50%, the five tastes
Son or fruit of Chinese magnoliavine extraction 1-50%, Chinese yam or yam extract 0-25%, mulberry leaf or mulberry-leaf extract 0-25%, Cr-enriched yeast
0.01-5%.
Preferably, primary raw material includes according to weight percent content:The Radix Astragali or Astragalus Root P.E 5-25%, the root of kudzu vine or Pueraria lobota
Root extract 2.5-12.5%, glutinous rehmannia or glutinous rehmannia extract 5-25%, the wind-weed or anemarrhena asphodefoides extract 1-10%, the tuber of dwarf lilyturf or the tuber of dwarf lilyturf carry
Take thing 2.5-12.5%, the fruit of Chinese wolfberry or Fructus lycii P.E 2.5-12.50%, the fruit of Chinese magnoliavine or fruit of Chinese magnoliavine extraction 1-10%, Chinese yam
Or yam extract 1-10%, mulberry leaf or mulberry-leaf extract 1-10%, Chinese yam or yam extract 1-10%, Cr-enriched yeast
0.01-4%.
The above-mentioned raw material with auxiliary hyperglycemic function is have chosen, according to Traditional Chinese medical theory and modern medicine study knot
Fruit, its prescription have collaboration hypoglycemic effect, without any incompatibility, can not only reduce blood glucose, it is each can also to strengthen body
Item function, protects islet tissue, improves the sensitiveness of insulin, delays or even prevent the generation of diabetic complication.
The Radix Astragali is the dry root of legume astragalus mongolicus or Astragalus membranacus, sweet, slightly warm in nature.The medicinal history of the Radix Astragali is swung
Long, be one of important drugs for quenching one's thirst of ancient times treatment, it has a tonifying Qi and lifting yang, inducing diuresis for removing edema, promote the production of body fluid blood-nourishing the effect of.Modern medicine
Pharmacological research shows that Radix Astragali water extract, astragalus polyose and Astragaloside IV have significant hypoglycemic effect, can also protect pancreas
Island β cells, prevention diabetic complication and improvement hemorheology index.
The root of kudzu vine is the dry root of legume pueraria lobata, Xin Gan and it is cool, have and inspire that the gas of the clear sun of taste is up, promotes the production of body fluid to quench thirst
Effect.The root of kudzu vine is rich in Flavonoid substances, and Puerarin therein has good reduction fasting blood-glucose, increase sugar tolerance, improves blood
Clear insulin level, improve the effect such as glycolipid metabolism, definite functions.
Glutinous rehmannia is the dried root of scrophulariaceae rehmannia glutinosa plant, sweet, cold in nature.Radix rehmanniae recen bitter cold is let out clearly, sweet matter profit, is had
Clearing heat and cooling blood, the effect of nourishing Yin and promoting production of body fluid.Modern pharmacology research shows that it is big that the oligosaccharides in glutinous rehmannia can adjust diabetes model
Mouse, the glycolipid metabolism of mouse, therapeutic action is respectively provided with to obese diabetes rat and diabetic nephropathy rats.
The wind-weed is the dry rhizome of the liliaceous plant wind-weed, bitter, sweet, cold in nature.The wind-weed is apt to the heat of clear Jiao of upper, middle and lower three, arrogates to oneself
Long Yin-nourishing and body fluid promoting is moisturized, and is the conventional Chinese medicine for treating diabetes.Research finds that the wind-weed has a variety of pharmacological activity, such as disease-resistant original
Microorganism, antipyretic and anti-inflammatory effect, antiplatelet aggregative activity and hypoglycemic effect.
The tuber of dwarf lilyturf be the liliaceous plant tuber of dwarf lilyturf dried root, sweet and slightly bitter taste, cold nature.The tuber of dwarf lilyturf both nourishing Yin and promoting production of body fluid and moistening lung is beneficial
Stomach, but clear nourishing the heart to keep a sound mind and relieving restlessness is calmed the nerves, can also moisten intestinal dryness and defaecation.Pharmacological research shows that the tuber of dwarf lilyturf has strengthen immunity, resisted
The pharmacological actions such as aging, resisting cardiovascular disease, anti-inflammatory, antibechic, while ophiopogonpolysaccharide has significant hypoglycemic, improvement pancreas islet
Element resistance and Renoprotective Effect.
The fruit of Chinese wolfberry be plant of Solanaceae lycium barbarum dry mature fruit, sweet, mild-natured partial temperature.Matrimony vine has nourishing liver
The effect of kidney, benefiting shrewd head.The fruit of Chinese wolfberry is widely used, and is the Chinese medicine of medicine-food two-purpose simply, and security is good.Modern medicine study
Show, LBP-X not only can also protect retina, treatment regards with hypoglycemic, repairing islet cells, recovery islet function
Retinopathy.
The fruit of Chinese magnoliavine is the dry mature fruit of magnoliaceae schisandra, sour, warm-natured.It is astringent or styptic treatment for spontaneous sweating with restraining, QI invigorating life
Tianjin, the effect of kidney calming.Because the fruit of Chinese magnoliavine has the function that to hold back cloudy Gu Yin, other medicines can be strengthened in the Ricipe for health care food
The nourishing Yin and promoting production of body fluid effect of material.Modern medicine study shows that Chinese Magnoliavine Fruit alcohol extract, water extract and fruit of Chinese magnoliavine decoction are respectively provided with simultaneously
Hypoglycemic, reducing blood lipid, protection kidney, the effect for repairing beta Cell of islet, its hypoglycemic effect are notable.
Chinese yam is the dry rhizome of Dioscoreaceae plant Chinese yam, sweet, mild-natured.The Chinese yam efficacy of a drug is gentle, and the puckery property held back, and both puts down
Tonifying Qi is cloudy, to control the good merchantable brand of the deficiency of vital energy or deficiency of both qi and yin, and enriching yin boost qi and promote the production of body fluid, commonly used to control kidney-yin deficiency and quenching one's thirst.Simultaneously
Chinese yam is also the very high integration of drinking and medicinal herbs food of nutritive value, have strengthen immunity, adjustment functions of intestines and stomach, hypoglycemic, reducing blood lipid,
Anti-aging and other effects.
Mulberry leaf are the dried leaf of moraceae plants mulberry, sweet, bitter, cold in nature.Contain 1-DNJ in mulberry leaf, be α-Portugal
The inhibitor of polyglycoside enzyme and glucoamylase, there is obvious suppression postprandial blood sugar to rise, lose weight and increase insulin is quick
The effect of perception.
Cr-enriched yeast is by way of manually developing, and using yeast as carrier, turns out the edible for being enriched with chromium
Feature yeast.Chromium is one of the essential trace elements of the human body, and modern study confirms that trivalent chromium is GTF (GTF)
Active part, mainly by GTF cooperate with and strengthen insulin effect, so as to influence the generation of carbohydrate, fat, protein
Thank.Cr-enriched yeast has edible safety, non-toxic, and human absorptivity is high, and it is many to supplement B family vitamin etc. while supplementing chromium
Advantage.
Also include filler and flavouring, described filler be selected from pregelatinized starch, microcrystalline cellulose, maltodextrin,
One or more in D-mannital, xylitol, maltitol, isomaltoketose, described flavouring be selected from flavoring essence,
One or both of citric acid;The adhesive and wetting agent used in pelletization is additionally included in, described adhesive is selected from
One or more in PVP, hydroxypropyl methylcellulose, sodium carboxymethylcellulose, starch slurry, described wetting agent are selected from purifying
One or both of water, ethanol.Addition filler and flavouring are to increase the mobility of material and adjustment granule
Taste, it is the demand for granule or capsule granulation to add adhesive and wetting agent.Wherein filler and flavouring, viscous
Mixture and wetting agent can need the property with material according to formula, and selection is added or do not added.
Preferably, filler and flavouring include according to weight percent content:Pregelatinized starch 5-50%, microcrystalline cellulose
Plain 5-30%, maltodextrin 5-50%, D-mannital 5-50%, xylitol 5-50%, maltitol 1-20%, different malt ketone
Sugared 1-20%, flavoring essence 0.1-5%, citric acid 0.1-5%;The adhesive and wetting agent used in pelletization is selected from pure
Change water 1-40%, ethanol 10-70%, PVP 1-40%, hydroxypropyl methylcellulose 1-40%, sodium carboxymethylcellulose 1-40%,
Starch slurry 1-40%.
Preferably, health food is granule or capsule.
The preparation method of above-mentioned assistant hypoglycemia healthcare food, comprises the following steps:
Granule:
(1) pulverize and sieve, the filler and flavouring that raw material, needs are added determine whether to carry out according to its particle sizes
Crush, if raw material, filler and flavouring be able to need not be crushed by 80-100 mesh sieves, if can not pass through 80-
100 mesh sieves, then need to pulverize and sieve, ensure that the granularity of each raw material, filler and flavouring is consistent, ensure follow-up well mixed;
(2) weigh, the filler and flavouring that raw material, needs are added carry out accurate weighing, standby;
(3) mix, load weighted each material is mixed according to formula;
(4) pelletize, according to the material properties mixed, select suitable adhesive and wetting agent, pelletized, reaching needs
The granularity 20-60 mesh wanted;
(5) particle made is packed, be put in storage.
Capsule:
(1) pulverize and sieve, the filler and flavouring that raw material, needs are added determine whether to carry out according to its particle sizes
Crush, if raw material, filler and flavouring be able to need not be crushed by 80-100 mesh sieves, if can not pass through 80-
100 mesh sieves, then need to pulverize and sieve, ensure that the granularity of each raw material, filler and flavouring is consistent, ensure follow-up well mixed;
(2) weigh, the filler and flavouring that raw material, needs are added carry out accurate weighing, standby;
(3) mix, load weighted each material is mixed according to formula;
Decide whether to be pelletized according to the material fluidity after formula combination, if good fluidity, be directly entered encapsulating capsule
The step of (5);If mobility is bad, the step of needing first to be pelletized (4), then the step of carry out encapsulating capsule (5);
(4) pelletize, according to the material properties mixed, select suitable adhesive and wetting agent, pelletized, reaching needs
The granularity 20-80 mesh wanted;
(5) encapsulating capsule, the material mixed or the particle made are subjected to encapsulating capsule;
(6) capsule filled is packed, be put in storage.
The present invention has the following technical effect that:
(1) assistant hypoglycemia healthcare food formulation manipulation of the present invention is according to Traditional Chinese medical theory and modern scientific research
Achievement, which is combined, carrys out prescription.In formula:The Radix Astragali, root of kudzu vine tonifying Qi and lifting yang, promote the production of body fluid to quench thirst, glutinous rehmannia, wind-weed heat-clearing enriching yin, the tuber of dwarf lilyturf, Chinese holly
Matrimony vine, Chinese yam promote the production of body fluid to quench thirst, the five internal organs with mending, cloudy Gu Yin is held back in fruit of Chinese magnoliavine nourshing kidney calming heart, and the 1- deoxidations open country buttocks in mulberry-leaf extract is mould
Element is potent alpha-glucosidase restrainer, can significantly reduce diabetic's fasting blood-glucose and postprandial blood sugar, in Cr-enriched yeast
It is the important component of glucose tolerance factor rich in trivalent chromium, insulin active can be increased, enhancing diabetes B is suffered from
Person's insulin sensitivity., can be from number of ways reasonable adjusting blood glucose without incompatibility between each raw material of the prescription.
(2) target group of the present invention is clear and definite, has the function that to treat both principal and secondary aspect of disease to diabetic, utilizes Traditional Chinese medical theory
Be combined with modern medicine, it is common to reduce the blood glucose target of high blood glucose crowd, while mitigate diabetic population complication and
Take side effect caused by Western medicine hypoglycemic medicine.
(3) granule and capsule preparation technology of the present invention is simple, and product instant, is easy to carry about with one, the scope of application
Extensively.
Embodiment
Specific examples below is the further explanation to method provided by the invention and technical scheme, but is not construed as
Limitation of the present invention.
Embodiment 1:
Choose 6 kinds of primary raw material Astragalus Root P.Es, kudzu root extract, glutinous rehmannia extract, ophiopogon japonicus extract, fruit of Chinese magnoliavine extraction
Thing, Cr-enriched yeast, addition maltodextrin, D-mannital, maltitol are filler and flavouring.The Radix Astragali, glutinous rehmannia, the tuber of dwarf lilyturf,
The fruit of Chinese magnoliavine is the article available for health food, and the root of kudzu vine is the material of integration of drinking and medicinal herbs, does not have incompatibility, group between each raw material
Safety issue is not present in side.
Specific formula composition is (weight percent):
Astragalus Root P.E:10-20
Kudzu root extract:5-10
Glutinous rehmannia extract:10-20
Ophiopogon japonicus extract:5-10
Schisandra chinens P.E:5-10
Cr-enriched yeast:0.1-2
Maltodextrin:20-40
D-mannital:10-30
Maltitol:10-20
70% ethanol:The 20%-50% of mixed material weight.
Production and processing method is as follows:
(1) pulverize and sieve:Above-mentioned supplementary material is pulverized and sieved, 100% by 80 mesh sieves, standby;
(2) weigh:Above-mentioned supplementary material is weighed by formula rate;
(3) mix:Load weighted material in (2) is loaded into stirring 30min in mixer;
(4) pelletize:According to the material properties mixed in (3), mass fraction is selected to be pelletized for 70% ethanol,
The granularity of grain reaches 20-60 mesh;
(5) pack:The particle made in (4) is dispensed, is put in storage.
Granule obtained by embodiment 1 has carried out auxiliary hyperglycemic function animal experiment:
First, test method:
(1) insulin damage hyperglycemia model method.
1 experimental animal and dosage:Experiment ICR mouse, cleaning grade, male, 26 ± 2g of body weight.Setup Experiments are basic, normal, high
Three dosage groups, respectively 0.25,0.5,1.5g/kg body weight, gavage capacity presses 0.1ml/10g batheroom scales.
2nd, intact animal hypoglycemic is tested:Take 20 mouse, after fasting 4 hours, take mouse tail blood to survey blood glucose, by blood sugar level
Be divided into 1 control group and 1 high dose group, every group 10, respectively gavage give deionized water and high dose sample, continuous 30
My god, after each group animal fasting 4 hours, fasting blood sugar is surveyed, compares two groups of mouse fasting blood sugars.
3rd, hyperglycemia model hypoglycemic is tested:
(1) islet damage hyperglycemia model:120 mouse take 15 fasting 4 hours at random, blood glucose are surveyed, as the batch
Animal basal plasma glucose value.Subsequent strict fasting 24 hours (free water), mouse tail vein injection alloxan 45mg/kg.BW,
Fasting 4 hours after 7 days, survey blood glucose.Screening fasting blood sugar is 10-25mmol/L mouse 52, is divided at random by blood sugar level
For 1 model control group and basic, normal, high dosage group.
(2) fasting blood-glucose and the measure of sugar tolerance:Gavage gives the sample of deionized water and various dose respectively, and continuous 30
My god, after each group animal fasting 4 hours, survey fasting blood sugar, i.e. 0 hour blood glucose value.Each dosage group gives various concentrations sample, mould
Type group control group gives same volume deionized water, and each group gavage gives glucose 2.0g/kg.BW after 20 minutes, determines to grape
The blood glucose value of 0.5,2 hour after sugar, compare fasting blood sugar and blood glucose decline percentage before and after each group mouse experiment;0.5、2.0
Hour blood glucose value and Area under the curve of blood glucose.
Blood glucose value before blood glucose rate of descent (%)=(blood glucose value after blood glucose value-experiment before experiment) × 100/ is tested
Area under the curve of blood glucose=(0h blood glucose+0.5h blood glucose) × 0.5/2+ (0.5h blood glucose+2h blood glucose) × 1.5/2
(2) experimental data counts:Experimental data is counted using SPSS11.5 statistical softwares.Negative control group and high agent
Each Indexes Comparison is examined using t between amount group.In addition to blood glucose rate of descent, model control group and each index of three dosage groups are using equal
Number ± standard deviationRepresent, compare between each group and variance analysis is used after homogeneity test of variance variance is neat.Blood glucose rate of descent
Using quartile (P25~P75) represent, the comparison between blood glucose rate of descent each group uses rank test.
2nd, experimental result
1st, sample is to normal and hyperglycemia model mouse weight influence
The sample of table 1 is to normal and hyperglycemia model mouse weight influence
From table 1, sample high dose group (feminine gender) mouse experiment initial stage, mid-term and it is final respectively and negative control group
Compare, there are no significant for difference (P > 0.05);The basic, normal, high dosage group mouse of sample is testing each phase respectively and model control group
Compare, there are no significant for difference (P > 0.05).
2nd, sample is to normal and hyperglycemia model mouse fasting blood-glucose influence
The sample of table 2 is to normal and hyperglycemia model mouse fasting blood-glucose influence
As shown in Table 2, mouse fasting blood sugar and negative control group compare before and after sample high dose group (feminine gender) experiment, poor
Different no conspicuousness (P > 0.05);Fasting blood sugar and blood glucose decline percentage before and after the basic, normal, high dosage group mouse test of sample
Compare respectively with model control group, there are no significant for difference (P > 0.05).
3rd, influence of the sample to hyperglycemia model glucose tolerance in mice
Influence of the sample of table 3 to hyperglycemia model glucose tolerance in mice
From table 3, compared with model control group, 2 hours blood glucose values of sample middle dose group sugar tolerance substantially reduce, difference
There is conspicuousness (P < 0.05).
Test result indicates that:Auxiliary drop blood is carried out using the assistant hypoglycemia healthcare food granule of embodiment 1 as sample
Sugared animal experiment, under this experiment condition, experimental result is the positive.
Embodiment 2:
Selection takes 7 kinds of primary raw material Astragalus Root P.Es, kudzu root extract, glutinous rehmannia extract, ophiopogon japonicus extract, fruits of Chinese wolfberry to carry
Thing, Schisandra chinens P.E, Cr-enriched yeast are taken, addition microcrystalline cellulose, magnesium stearate are filler.The Radix Astragali, glutinous rehmannia, the tuber of dwarf lilyturf, five
Taste is the article available for health food, and the root of kudzu vine, the Chinese medicine that the fruit of Chinese wolfberry is integration of drinking and medicinal herbs, Cr-enriched yeast belong to nutrient thing
Matter, there is no incompatibility between each raw material, safety issue is not present in prescription.
Specific formula composition is (weight percent):
Astragalus Root P.E:10-20
Kudzu root extract:5-10
Glutinous rehmannia extract:10-20
Ophiopogon japonicus extract:5-10
Fructus lycii P.E:5-10
Schisandra chinens P.E:5-10
Cr-enriched yeast:0.1-2
Microcrystalline cellulose:20-40
Magnesium stearate 0.5-1.5.
Production and processing method is as follows:
(1) pulverize and sieve:Above-mentioned supplementary material is pulverized and sieved, 100% by 80 mesh sieves, standby;
(2) weigh:Above-mentioned supplementary material is weighed by formula rate;
(3) mix:Load weighted material in (2) is loaded into stirring 30min in mixer;
(4) encapsulating capsule:The material mixed in (3) is subjected to encapsulating capsule;
(5) pack:The capsule filled in (4) is dispensed, is put in storage.
Described above is only the preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art
For member, under the premise without departing from the principles of the invention, various changes can be carried out to these features and embodiment or equivalent are replaced
Change.In addition, under the teachings of the present invention, these features and embodiment can be modified to adapt to particular situation and material
And mend and depart from the spirit and scope of the present invention.Therefore, the present invention is not limited to the particular embodiment disclosed, Suo Youluo
Enter the embodiment in the range of claims hereof and belong to protection scope of the present invention.
Claims (8)
1. a kind of health food of auxiliary hyperglycemic, it is characterised in that include following components according to weight percentage:The Radix Astragali or
Astragalus Root P.E 1-50%, the root of kudzu vine or kudzu root extract 1-50%, glutinous rehmannia or glutinous rehmannia extract 1-50%, the wind-weed or wind-weed extraction
Thing 0-25%, the tuber of dwarf lilyturf or ophiopogon japonicus extract 1-50%, the fruit of Chinese wolfberry or Fructus lycii P.E 0-50%, the fruit of Chinese magnoliavine or fruit of Chinese magnoliavine extraction
1-50%, Chinese yam or yam extract 0-25%, mulberry leaf or mulberry-leaf extract 0-25%, Cr-enriched yeast 0.01-5%.
2. the health food of auxiliary hyperglycemic as claimed in claim 1, it is characterised in that raw material is according to weight percent content
For:The Radix Astragali or Astragalus Root P.E 5-25%, the root of kudzu vine or kudzu root extract 2.5-12.5%, glutinous rehmannia or glutinous rehmannia extract 5-25%,
The wind-weed or anemarrhena asphodefoides extract 1-10%, the tuber of dwarf lilyturf or ophiopogon japonicus extract 2.5-12.5%, the fruit of Chinese wolfberry or Fructus lycii P.E 2.5-
12.50%th, the fruit of Chinese magnoliavine or fruit of Chinese magnoliavine extraction 1-10%, Chinese yam or yam extract 1-10%, mulberry leaf or mulberry-leaf extract 1-
10%th, Chinese yam or yam extract 1-10%, Cr-enriched yeast 0.01-4%.
3. the health food of auxiliary hyperglycemic as claimed in claim 1, it is characterised in that also including filler and flavouring,
Described filler is selected from pregelatinized starch, microcrystalline cellulose, maltodextrin, D-mannital, xylitol, maltitol, different
One or more in maltulose, described flavouring are selected from one or both of flavoring essence, citric acid.
4. the health food of auxiliary hyperglycemic as claimed in claim 1, it is characterised in that be additionally included in pelletization and use
Adhesive and wetting agent, described adhesive is in PVP, hydroxypropyl methylcellulose, sodium carboxymethylcellulose, starch slurry
One or more, described wetting agent is selected from purified water, one or both of ethanol.
5. the health food of auxiliary hyperglycemic as claimed in claim 4, it is characterised in that described filler and flavouring exists
It is according to weight percent content in raw material:Pregelatinized starch 5-50%, microcrystalline cellulose 5-30%, maltodextrin 5-50%,
D-mannital 5-50%, xylitol 5-50%, maltitol 1-20%, isomaltoketose 1-20%, flavoring essence 0.1-
5%th, citric acid 0.1-5%.
6. the health food of auxiliary hyperglycemic as claimed in claim 5, it is characterised in that described adhesive and wetting agent exists
It is according to weight percent content in raw material:Purified water 1-40%, ethanol 10-70%, PVP 1-40%, hydroxypropyl methylcellulose
1-40%, sodium carboxymethylcellulose 1-40%, starch slurry 1-40%.
7. the health food of auxiliary hyperglycemic as claimed in claim 6, it is characterised in that the health care of described auxiliary hyperglycemic
Food is granule or capsule.
8. the health food of the auxiliary hyperglycemic as any one of claim 3-7, it is characterised in that including following step
Suddenly:
(1) alternatively, pulverize and sieve, raw material, filler and flavouring are crossed into 80-100 mesh sieves;
(2) weigh, raw material, filler and flavouring are weighed, it is standby;
(3) mix, load weighted material is mixed according to formula;
(4) alternatively, adhesive and wetting agent are added, is pelletized, reaches the granularity 20-60 mesh of needs;
(5) pack, storage or further encapsulating capsule, the capsule filled is packed, is put in storage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711238078.7A CN107801990A (en) | 2017-11-30 | 2017-11-30 | A kind of health food of auxiliary hyperglycemic and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711238078.7A CN107801990A (en) | 2017-11-30 | 2017-11-30 | A kind of health food of auxiliary hyperglycemic and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107801990A true CN107801990A (en) | 2018-03-16 |
Family
ID=61582281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711238078.7A Pending CN107801990A (en) | 2017-11-30 | 2017-11-30 | A kind of health food of auxiliary hyperglycemic and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107801990A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109007785A (en) * | 2018-09-26 | 2018-12-18 | 上饶市康可得生物科技有限公司 | A kind of auxiliary hyperglycemic blood fat reducing healthcare food |
CN110314196A (en) * | 2019-08-17 | 2019-10-11 | 哈尔滨工业大学 | A kind of preparation method of mulberry leaf compound hypoglycemic instant |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1618446A (en) * | 2003-11-19 | 2005-05-25 | 王锦刚 | Medicine for treating diabetes, and its prepn. method |
CN106666312A (en) * | 2017-01-11 | 2017-05-17 | 大连雅威特生物技术股份有限公司 | Health-care food for assisting blood glucose decreasing and preparation method of granule and capsule thereof |
-
2017
- 2017-11-30 CN CN201711238078.7A patent/CN107801990A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1618446A (en) * | 2003-11-19 | 2005-05-25 | 王锦刚 | Medicine for treating diabetes, and its prepn. method |
CN106666312A (en) * | 2017-01-11 | 2017-05-17 | 大连雅威特生物技术股份有限公司 | Health-care food for assisting blood glucose decreasing and preparation method of granule and capsule thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109007785A (en) * | 2018-09-26 | 2018-12-18 | 上饶市康可得生物科技有限公司 | A kind of auxiliary hyperglycemic blood fat reducing healthcare food |
CN110314196A (en) * | 2019-08-17 | 2019-10-11 | 哈尔滨工业大学 | A kind of preparation method of mulberry leaf compound hypoglycemic instant |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019101804A4 (en) | Traditional Chinese medicine medical nutrition therapy-based composition for treating diabetes, and application | |
CN103285231B (en) | Medicine composition for diabetes adjunctive therapy and preparation method thereof | |
CN106666312A (en) | Health-care food for assisting blood glucose decreasing and preparation method of granule and capsule thereof | |
CN104288501A (en) | Blood glucose reducing particle and preparation method thereof | |
CN104784505B (en) | A kind of Dendrobium officinale health product of auxiliary hyperglycemic and preparation method thereof | |
CN109549971A (en) | A kind of functional food and preparation method thereof adjusting hyperglycemia | |
CN104055871A (en) | Traditional Chinese medicinal composition for improving sleeping quality and application of traditional Chinese medicinal composition | |
CN106819833A (en) | A kind of noodles of hypoglycemic Adjust-blood lipid and preparation method thereof | |
CN109527540A (en) | A kind of preparation method of sea-buckthorn antihypelipidemic foodstuff | |
CN103223111B (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and preparation method thereof | |
CN104383259A (en) | Bitter gourd and mulberry leaf chromium-rich capsule and preparation method thereof | |
CN108578544A (en) | A kind of Chinese medicine composition and the preparation method and application thereof with blood sugar reducing function | |
CN108523129A (en) | A kind of auxiliary hyperglycemic composition and preparation method thereof | |
CN103637179B (en) | Food composition with functions of lowering blood sugar and blood fat and improving fatty liver | |
CN106176953A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, Fructus Momordicae and Folium Mori | |
CN106177183A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori | |
CN106723029A (en) | A kind of health food and its preparation technology with auxiliary hyperglycemic function | |
CN104474472B (en) | Buccal lozenge of lectuce tea and its production method with three high drop effect | |
CN107801990A (en) | A kind of health food of auxiliary hyperglycemic and preparation method thereof | |
CN103637190A (en) | Functional food for prevention and treatment of diabetes and its preparation method | |
CN108785412A (en) | It is a kind of that there is the composition and preparation method thereof for improving sleep function | |
CN106177432A (en) | A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja, Folium Mori, green tea and Rhizoma Polygonati Odorati | |
CN111298021A (en) | Traditional Chinese medicine composition for treating functional constipation | |
CN108704070A (en) | A kind of drug of the treatment diabetes of Integrated TCM | |
CN103705860A (en) | Traditional Chinese medicine composition for treating infant jaundice and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180316 |
|
RJ01 | Rejection of invention patent application after publication |